The University of Southampton
University of Southampton Institutional Repository

The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B

The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B
The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B

Human soluble CD52 is a short glycopeptide comprising 12 amino acids (GQNDTSQTSSPS) which functions as an immune regulator by sequestering the pro-inflammatory high mobility group box protein 1 (HMGB1) and suppressing immune responses. Recombinant CD52 has been shown to act as a broad anti-inflammatory agent, dampening both adaptive and innate immune responses. This short glycopeptide is heavily glycosylated, with a complex sialylated N-linked glycan at N3 and reported O-linked glycosylation possible on several serine and threonine residues. Previously we demonstrated that specific glycosylation features of CD52 are essential for its immunosuppressive function, with terminal α-2,3-linked sialic acids required for binding to the inhibitory SIGLEC-10 receptor leading to T-cell suppression. Using high resolution mass spectrometry, we have further characterized the N- and O-linked glycosylation of Expi293 recombinantly produced CD52 at a glycopeptide and released glycan level, accurately determining glycan heterogeneity of both N- and O-linked glycosylation, and localizing the site of O-glycosylation to T8 with high confidence and direct spectral evidence. This detailed knowledge of CD52 glycosylation informed the construction of a model system, which we analyzed by molecular dynamics simulations to understand the mechanism of recognition and define interactions between bioactive CD52, HMGB1 and the SIGLEC-10 receptor. Our results confirm the essential role of glycosylation, more specifically hyper-sialylation, in the function of CD52, and identify at the atomistic level specific interactions between CD52 glycans and the Box B domain of HMGB1 that determine recognition, and the stability of the CD52/HMGB1 complex. These insights will inform the development of synthetic CD52 as an immunotherapeutic agent.

CD52, glycomics, glycoprotein, HMGB1, mass spectrometry, molecular dynamics
0021-9258
DeBono, Nicholas J.
425ceaf9-ef4a-40ae-a7c9-21b34511276a
D'Andrea, Silvia
05bebc27-32c5-4195-8117-e909181af2f4
Bandala-Sanchez, Esther
525e49c4-936e-4136-bf84-8f8247947fcf
Goddard-Borger, Ethan
4a77934b-a3b4-439b-b213-f6380ca435d1
Zenaidee, Muhammad A.
81f377c7-4dda-4f2c-a39e-5d05be10e824
Moh, Edward S.X.
3f0cf876-8863-44be-bcfe-d485d5341861
Fadda, Elisa
11ba1755-9585-44aa-a38e-a8bcfd766abb
Harrison, Leonard C.
0ec7440f-4a73-48b7-b024-93f44c62a558
Packer, Nicolle H.
ad55bbf3-4fa2-407f-a2e3-6392af253ce2
DeBono, Nicholas J.
425ceaf9-ef4a-40ae-a7c9-21b34511276a
D'Andrea, Silvia
05bebc27-32c5-4195-8117-e909181af2f4
Bandala-Sanchez, Esther
525e49c4-936e-4136-bf84-8f8247947fcf
Goddard-Borger, Ethan
4a77934b-a3b4-439b-b213-f6380ca435d1
Zenaidee, Muhammad A.
81f377c7-4dda-4f2c-a39e-5d05be10e824
Moh, Edward S.X.
3f0cf876-8863-44be-bcfe-d485d5341861
Fadda, Elisa
11ba1755-9585-44aa-a38e-a8bcfd766abb
Harrison, Leonard C.
0ec7440f-4a73-48b7-b024-93f44c62a558
Packer, Nicolle H.
ad55bbf3-4fa2-407f-a2e3-6392af253ce2

DeBono, Nicholas J., D'Andrea, Silvia, Bandala-Sanchez, Esther, Goddard-Borger, Ethan, Zenaidee, Muhammad A., Moh, Edward S.X., Fadda, Elisa, Harrison, Leonard C. and Packer, Nicolle H. (2025) The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B. Journal of Biological Chemistry, 301 (4), [108350]. (doi:10.1016/j.jbc.2025.108350).

Record type: Article

Abstract

Human soluble CD52 is a short glycopeptide comprising 12 amino acids (GQNDTSQTSSPS) which functions as an immune regulator by sequestering the pro-inflammatory high mobility group box protein 1 (HMGB1) and suppressing immune responses. Recombinant CD52 has been shown to act as a broad anti-inflammatory agent, dampening both adaptive and innate immune responses. This short glycopeptide is heavily glycosylated, with a complex sialylated N-linked glycan at N3 and reported O-linked glycosylation possible on several serine and threonine residues. Previously we demonstrated that specific glycosylation features of CD52 are essential for its immunosuppressive function, with terminal α-2,3-linked sialic acids required for binding to the inhibitory SIGLEC-10 receptor leading to T-cell suppression. Using high resolution mass spectrometry, we have further characterized the N- and O-linked glycosylation of Expi293 recombinantly produced CD52 at a glycopeptide and released glycan level, accurately determining glycan heterogeneity of both N- and O-linked glycosylation, and localizing the site of O-glycosylation to T8 with high confidence and direct spectral evidence. This detailed knowledge of CD52 glycosylation informed the construction of a model system, which we analyzed by molecular dynamics simulations to understand the mechanism of recognition and define interactions between bioactive CD52, HMGB1 and the SIGLEC-10 receptor. Our results confirm the essential role of glycosylation, more specifically hyper-sialylation, in the function of CD52, and identify at the atomistic level specific interactions between CD52 glycans and the Box B domain of HMGB1 that determine recognition, and the stability of the CD52/HMGB1 complex. These insights will inform the development of synthetic CD52 as an immunotherapeutic agent.

Text
PIIS0021925825001991 - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

e-pub ahead of print date: 25 February 2025
Published date: 1 April 2025
Additional Information: Publisher Copyright: © 2025 The Authors
Keywords: CD52, glycomics, glycoprotein, HMGB1, mass spectrometry, molecular dynamics

Identifiers

Local EPrints ID: 501843
URI: http://eprints.soton.ac.uk/id/eprint/501843
ISSN: 0021-9258
PURE UUID: c0dbe5a6-4a28-4925-a8ce-65b31b1a0b69
ORCID for Elisa Fadda: ORCID iD orcid.org/0000-0002-2898-7770

Catalogue record

Date deposited: 10 Jun 2025 18:32
Last modified: 22 Aug 2025 02:42

Export record

Altmetrics

Contributors

Author: Nicholas J. DeBono
Author: Silvia D'Andrea
Author: Esther Bandala-Sanchez
Author: Ethan Goddard-Borger
Author: Muhammad A. Zenaidee
Author: Edward S.X. Moh
Author: Elisa Fadda ORCID iD
Author: Leonard C. Harrison
Author: Nicolle H. Packer

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×